九洲药业
(603456)
| 流通市值：152.18亿 | | | 总市值：152.18亿 |
| 流通股本：8.82亿 | | | 总股本：8.82亿 |
| 利润表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 营业总收入 | 2,575,246,576.12 | 1,200,661,700.09 | 5,508,595,171.33 | 4,160,487,725.65 |
| 营业总成本 | 2,064,924,507.55 | 977,467,580.38 | 4,293,596,413.64 | 3,195,334,808.19 |
| 其他经营收益 | | | | |
| 营业利润 | 487,209,112.25 | 219,838,486.07 | 924,945,257.44 | 912,351,045.88 |
| 利润总额 | 485,430,456.73 | 219,857,867.46 | 919,451,398.52 | 909,807,395.65 |
| 净利润 | 380,694,022.63 | 168,270,923.2 | 728,543,117.48 | 748,674,344.04 |
| 每股收益 | | | | |
| 其他综合收益 | -17,745,125.97 | -8,776,591.02 | -1,972,075.01 | 3,761,640.59 |
| 综合收益总额 | 362,948,896.66 | 159,494,332.18 | 726,571,042.47 | 752,435,984.63 |
| 资产负债表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 流动资产: | | | | |
| 流动资产合计 | 5,623,189,100.53 | 5,364,104,245.95 | 5,537,378,379.79 | 5,518,729,793.69 |
| 非流动资产: | | | | |
| 非流动资产合计 | 5,014,105,955.13 | 5,224,326,737.83 | 5,065,608,803.92 | 5,200,007,694.16 |
| 资产总计 | 10,637,295,055.66 | 10,588,430,983.78 | 10,602,987,183.71 | 10,718,737,487.85 |
| 流动负债: | | | | |
| 流动负债合计 | 1,439,163,389.68 | 1,401,203,792.38 | 1,577,607,478.05 | 1,626,561,569.92 |
| 非流动负债: | | | | |
| 非流动负债合计 | 237,666,667.8 | 234,067,928.55 | 234,781,383.17 | 267,966,711.58 |
| 负债合计 | 1,676,830,057.48 | 1,635,271,720.93 | 1,812,388,861.22 | 1,894,528,281.5 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 8,900,685,268.94 | 8,890,493,786.65 | 8,724,119,572.52 | 8,755,178,673.48 |
| 股东权益合计 | 8,960,464,998.18 | 8,953,159,262.85 | 8,790,598,322.49 | 8,824,209,206.35 |
| 负债和股东权益合计 | 10,637,295,055.66 | 10,588,430,983.78 | 10,602,987,183.71 | 10,718,737,487.85 |
| 现金流量表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 2,733,026,126.07 | 1,351,032,016.99 | 5,849,553,071.59 | 4,725,571,418.11 |
| 经营活动现金流出小计 | 2,179,587,456.31 | 1,215,085,027.51 | 4,025,306,849.66 | 3,383,566,378.62 |
| 经营活动产生的现金流量净额 | 553,438,669.76 | 135,946,989.48 | 1,824,246,221.93 | 1,342,005,039.49 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 523,315,128.29 | 344,992,664.57 | 10,360,577.08 | 5,822,915.53 |
| 投资活动现金流出小计 | 789,182,320.96 | 487,399,226.62 | 2,042,460,578.66 | 534,459,528.27 |
| 投资活动产生的现金流量净额 | -265,867,192.67 | -142,406,562.05 | -2,032,100,001.58 | -528,636,612.74 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 90,000,000 | 90,000,000 | 470,000,000 | 470,000,000 |
| 筹资活动现金流出小计 | 344,967,162.83 | 51,230,030 | 1,382,712,697.9 | 1,305,569,005.33 |
| 筹资活动产生的现金流量净额 | -254,967,162.83 | 38,769,970 | -912,712,697.9 | -835,569,005.33 |
| 汇率变动对现金及现金等价物的影响 | -32,905,539.65 | -18,500,052.73 | -17,015,588.67 | -4,113,355 |
| 现金及现金等价物净增加额 | -301,225.39 | 13,810,344.7 | -1,137,582,066.22 | -26,313,933.57 |
| 期末现金及现金等价物余额 | 1,455,798,703.35 | 1,469,910,273.44 | 1,456,099,928.74 | 2,567,368,061.39 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | -301,225.39 | - | -1,137,582,066.22 | - |
最新报告期：2026-08-17| 研究机构 | 分析师 | 预测每股收益(元) | 更新日 |
| 2026年 | 2027年 | 2028年 |
| 天风证券 | 杨松,刘一伯 | 0.93 | 1.03 | 1.19 | 2026-08-17 |
| 长城国瑞证券 | 胡晨曦,魏钰琪 | 0.92 | 1.00 | 1.05 | 2026-08-10 |
| 招商证券 | 梁广楷,肖笑园,许菲菲 | 0.89 | 1.00 | 1.18 | 2026-08-09 |
| 中信建投 | 王云鹏,袁清慧 | 0.92 | 1.06 | 1.24 | 2026-08-07 |
| 浙商证券 | 盖文化,郭双喜 | 0.95 | 1.07 | 1.28 | 2026-08-05 |